Preferred Label : Somapacitan;

UNII : 8FOJ430U94;

CAS number : 1338578-34-9;

NCI Metathesaurus CUI : CL553726;

Détails


Consulter ci-dessous une sélection des principales ressources :

Vous pouvez consulter :


https://www.ema.europa.eu/en/medicines/human/EPAR/sogroya
2021
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
Somapacitan
Somapacitan
human growth hormone
human growth hormone
orphan drug production
hormone replacement therapy
adult
Growth Hormone Deficiency
injections, subcutaneous
product surveillance, postmarketing
Adult growth hormone deficiency (disorder)
aged
drug interactions
pregnancy
breast feeding
somapacitan
human growth hormone
Prolonged-Action preparations
drug evaluation, preclinical
Product containing only somapacitan in parenteral dose form (medicinal product form)
Delayed-Action preparations

---
Nous contacter.
28/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.